The CHMP recommends marketing approval to GSK's Vocabria plus JNJ's Rekambys for treating HIV-1 infection in adolescents aged 12 years and older.

GSK (GSK) announced the Committee for Medicinal Products for Human Use, CHMP, of the European Medicines Agency, EMA, has recommended expanding the approval of Jemperli in combination with chemotherapy ...

In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a ...

GSK is hosting the third annual RespiVerse Meeting in Bangkok, Thailand. The event brings together renowned international ...

But enrollment for all clinical studies of infant RSV vaccines is now on hold due to safety concerns, explained a Dec. 11 ...

Gilead Sciences, Inc. GILD announced that the Committee for Medicinal Products for Human Use (“CHMP”) of the European ...

In 2019, evidence showed that an impurity in drug degrades over time to form probable carcinogenic compound. Ranitidine is ...

European stocks closed broadly lower on Tuesday weighed down by a weak German business sentiment, political uncertainty in Germany ...

The Global Prize Innovation in Desalination (GPID) has awarded more than SAR 10M in prize funding per year over a three-year ...

麦克森公司在北美医药市场的市占率超1/3，员工数超7.8万名。 作为一家链接药品产业链上下游的产业互联网平台，为美国医疗保健行业提供了广泛的基础设施网络, ...

Standard Investments, which owns 11% of the FTSE 250 firm, urged the board to launch a strategic review to look at 'a sale of ...

CTLA-4 inhibitors are a well-established market in cancer care, and they are expected to grow significantly in the coming ...